Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.2050 (-10.73%) ($2.2050 - $2.2050) on Thu. May. 5, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.13% (three month average) | RSI | 34 | Latest Price | $2.2050(-10.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.1% a day on average for past five trading days. | Weekly Trend | CGEN declines -4.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IBB(99%) SMH(99%) VT(97%) IBUY(95%) ARKK(94%) | Factors Impacting CGEN price | CGEN will decline at least -2.065% in a week (0% probabilities). TIP(-21%) UUP(-12%) SHY(-11%) BNDX(6%) BND(13%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.065% (StdDev 4.13%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-14.4(-753.06%) | Resistance Level | $2.52 | 5 Day Moving Average | $2.33(-5.36%) | 10 Day Moving Average | $2.36(-6.57%) | 20 Day Moving Average | $2.52(-12.5%) | To recent high | -36.1% | To recent low | 0% | Market Cap | $182m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |